SCORPION THERAPEUTICS
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.
SCORPION THERAPEUTICS
Industry:
Biotechnology Health Care Life Science
Founded:
2020-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.scorpiontx.com
Total Employee:
51+
Status:
Active
Contact:
(212) 841-1015
Total Funding:
270 M USD
Technology used in webpage:
ReCAPTCHA Mimecast DocuSign SparkPost
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Board_observer
2020-04-01
Current Employees Featured
Gaddy Getz Founder @ Scorpion Therapeutics
Founder
Chih-Chiang Tsou Director, Head of Chemical Biology Informatics @ Scorpion Therapeutics
Director, Head of Chemical Biology Informatics
2022-01-01
Adam Friedman President @ Scorpion Therapeutics
President
2021-08-01
Keith Flaherty Co-Founder & Board Member @ Scorpion Therapeutics
Co-Founder & Board Member
Brian Piper Chief Financial Officer @ Scorpion Therapeutics
Chief Financial Officer
2021-11-01
Liron Bar-Peled Founder @ Scorpion Therapeutics
Founder
Founder
Investors List
Boxer Capital
Boxer Capital investment in Series B - Scorpion Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Scorpion Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Scorpion Therapeutics
OrbiMed
OrbiMed investment in Series B - Scorpion Therapeutics
Vida Ventures
Vida Ventures investment in Series B - Scorpion Therapeutics
Nextech Invest
Nextech Invest investment in Series B - Scorpion Therapeutics
Omega Funds
Omega Funds investment in Series B - Scorpion Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Scorpion Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series B - Scorpion Therapeutics
Invus
Invus investment in Series B - Scorpion Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-22 | Scorpion Therapeutics Announces Appointment of Brian Piper as Chief Financial Officer |
Official Site Inspections
http://www.scorpiontx.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.84 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Scorpion Therapeutics"
Scorpion Therapeutics - Crunchbase Company Profile …
Organization. Scorpion Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Scorpion Therapeutics - LinkedIn
Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated discovery ...See details»
Scorpion - 2025 Company Profile & Funding - Tracxn
Mar 25, 2025 Scorpion - Developer of drugs for the treatment of cancer. Raised a total funding of $420M over 3 rounds from 21 investors. Founded by Gary D Glick in the year 2020.See details»
Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα ...
The acquisition will expand Lilly's oncology pipeline with STX-478, the differentiated and potentially best-in-class, mutant-selective PI3Kα inhibitor currently in a Phase 1/2 clinical trial. …See details»
Scorpion Therapeutics Information - RocketReach
Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated discovery …See details»
Scorpion Therapeutics Company Profile | Management and
SQL International Organization for Standardization . Python Python Software Foundation . Java Oracle . Other Vertical Industries Software (3 Technologies) ... John_Smith@scorpiontx.com: …See details»
Chief Scientific Officer at Scorpion Therapeutics - The Org
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, …See details»
Scorpion Therapeutics - Craft
Scorpion Therapeutics has 5 employees across 3 locations and $108 m in total funding,. See insights on Scorpion Therapeutics including office locations, competitors, revenue, financials, …See details»
Scorpion Therapeutics - Built In
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, …See details»
Scorpion Therapeutics - Work in biotech
Scorpion Therapeutics is expanding the potential of precision medicine to cancer patients. Using their fully integrated discovery platform that uses cancer biology, medicinal chemistry, …See details»
Scorpion Therapeutics CEO and Key Executive Team | Craft.co
Scorpion Therapeutics's Chief Scientific Officer is Darrin Stuart. Scorpion Therapeutics's key executives include Darrin Stuart and 1 others.See details»
Scorpion Therapeutics - VentureRadar
Auto Analyst Score: 50 | scorpiontx.com. VentureRadar Popularity. High. VentureRadar Popularity: High. The popularity score combines profile views, clicks and the number of times …See details»
Scorpion Therapeutics Appoints Adam Friedman, M.D., Ph.D., as …
Jan 4, 2024 Friedman, who joined as part of Scorpion’s founding team and most recently served as President, Corporate Strategy and Business Development, succeeds Axel Hoos, M.D., …See details»
Scorpion Therapeutics' Leadership Team - The Org
About. The leadership team at Scorpion Therapeutics has a long history of experience and education in the field of chemistry and biology. They have worked at some of the biggest …See details»
Scorpion Therapeutics Announces $150 Million Series C Financing …
BOSTON, July 16, 2024--Scorpion Therapeutics, Inc. ("Scorpion"), a pioneering clinical-stage oncology company dedicated to transforming the lives of cancer patients by redefining the …See details»
Scorpion Therapeutics to Present Preclinical Data for Potential Best …
Nov 21, 2022 For more information, visit www.scorpiontx.com. 1 American Cancer Society, The Cancer Genome Atlas Contacts. Media Contact: Ravi Moorthy Scorpion Therapeutics …See details»
Scorpion Therapeutics Appoints Adam Friedman, M.D., Ph.D
Jan 4, 2024 Dr. Friedman, who joined as part of Scorpion’s founding team and most recently served as President, Corporate Strategy and Business Development, succeeds Axel Hoos, …See details»
Scorpion Therapeutics Careers, Perks + Culture | Built In
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, …See details»
What is Scorpion Therapeutics? Company Culture, Mission, Values
See what employees say it's like to work at Scorpion Therapeutics. Salaries, reviews, and more - all posted by employees working at Scorpion Therapeutics.See details»
Scorpion Tx Raises $150M For Cancer Pipeline with PI3Kα Inhibitor
Jul 17, 2024 Scorpion Therapeutics has closed a $150 million series C to support development of its precision oncology pipeline, including lead compound STX-478—a highly specific PI3K α …See details»